About CapsoVision, Inc

CapsoVision, Inc. operates in the electromedical & electrotherapeutic apparatus industry. listed on NASDAQ. headquartered in SARATOGA, CA.

Investment Context for CV

CapsoVision, Inc (CV) is publicly traded on NASDAQ within the Healthcare sector , specifically in the Electromedical & Electrotherapeutic Apparatus industry. The company is headquartered in SARATOGA, CA.

Business classification: According to SEC filings, CapsoVision, Inc falls under SIC code 3845 — Electromedical & Electrotherapeutic Apparatus. This classification helps investors compare the company against peers in similar regulatory and operational environments.

Sector outlook: Companies in the Healthcare sector typically share exposure to similar macroeconomic factors — interest rates, regulatory shifts, and consumer demand patterns specific to this industry vertical. Investors evaluating CV should benchmark against other Healthcare stocks for comparative analysis.

Industry-specific factors: The Electromedical & Electrotherapeutic Apparatus industry has specific competitive dynamics — market share concentration, supply chain dependencies, and capital intensity that affect valuation. Compare CV with peer companies in Electromedical & Electrotherapeutic Apparatus to assess relative positioning.

Regulatory disclosures: With CIK 0001378325, CapsoVision, Inc files mandatory disclosures with the U.S. Securities and Exchange Commission. These include 10-K annual reports, 10-Q quarterly reports, and 8-K material event filings — accessible via the official SEC EDGAR portal for fundamental research.

This page is for educational and research purposes only and does not constitute investment advice. Always conduct independent due diligence and consult a licensed financial advisor before making investment decisions.

Company Information

Industry (SIC)
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Exchange
NASDAQ
State / Country
CA
City
SARATOGA
CIK
0001378325
Important Disclaimer This information is sourced from SEC filings and public data. It is for educational and informational purposes only and is NOT financial advice. Not a recommendation to buy, sell, or hold any security. Consult a qualified financial advisor before making investment decisions.